MULTABODY
"MULTABODY" is a word mark owned by Radiant Biotherapeutics, filed at the USPTO on July 12, 2023. It has been allowed and covers classes 1, 5, 42 and 45.
- Status
- Allowed
- Since June 1, 2026
- Filed
- July 12, 2023
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 98081053
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 4 classes
Who owns MULTABODY
The owner and representative on file with the office.
Owner
Radiant Biotherapeutics
Toronto, Ontario, Canada
Representative
Tom M. Monagan
Neal & McDevitt, LLC
What the mark covers
The products and services MULTABODY is filed for, grouped by Nice class.
Chemical, biochemical, biological, and biotechnological, preparations, namely, antibodies, bi- and multispecific antibodies as well as fragments, monovalent antibodies, derivatives of conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases; biochemicals, namely, monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases
Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, bi and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases; pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases
Medical, scientific and biological research; research in antibodies, bi and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these and development services of new pharmaceutical products based on antibodies, bi and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; development of pharmaceutical preparations and medicines containing antibodies, bi- and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these; medical and scientific research, namely, biological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases
Licensing of intellectual property in the field of medicine
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of approval of extension request e-mailed
- Sou extension 2 granted
- Sou extension 2 filed
- Sou teas extension received
- Notice of approval of extension request e-mailed
- Sou extension 1 granted
- Sou extension 1 filed
- Sou teas extension received
- Teas change of correspondence received
- Attorney/dom.rep.revoked and/or appointed
10 earlier steps on the official record.
About MULTABODY
Who owns the trademark "MULTABODY"?
The USPTO trademark "MULTABODY" (application 98081053) is owned by Radiant Biotherapeutics.
What is the status of "MULTABODY"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull MULTABODY and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2be4-f47a-73ae-90f1-6e45021b6dda
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2be4-f47a-73ae-90f1-6e45021b6dda",
"object": "trademark",
"mark_text": "MULTABODY",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "98081053",
"filing_date": "2023-07-12",
"nice_classes": [
1,
5,
42,
45
],
"owners": [
{
"name": "Radiant Biotherapeutics",
"entity_id": null
}
]
}